Cross-Sector Mid-Cap Operations in Focus After Mixed Q2 2026 Print

A cross-section of mid-cap publicly traded companies, spanning tech hardware to primary resource extraction, have posted divergent fiscal results for the second quarter of 2026, driven largely by end-market specifics and debt-restructuring maneuvers, according to recent corporate filings and people familiar with the matter.

Lattice Semiconductor (LSCC.US)

Lattice Semiconductor has trended higher year-to-date. In August 2026, the company reported Q2 revenue surged 62% year-over-year to USD 173.3 million, with gross margin reaching 71.7%. Management is targeting sustained growth fueled by data center infrastructure and industrial automation, while finalizing its July acquisition of AMI to expand its recurring revenue base.

Quantum-Si (QSI.US)

Quantum-Si shares have been under pressure. During its August 22, 2026 earnings call, the company announced the delayed launch of its Proteus protein sequencing platform. Q2 revenue stood at USD 344,000, as net loss narrowed to USD 23.5 million. The company expects its current cash runway to fund operations into the second quarter of 2028.

Dave (DAVE.US)

The fintech platform Dave saw a recent pullback. In Q2 2026, Dave posted revenue of USD 170.79 million, narrowly missing estimates, while EPS of USD 0.49 also trailed consensus. Bank of America reduced its stake in the firm by 41.7% in Q1 2026, according to regulatory filings. The company maintained its full-year 2026 EPS forecast between USD 17.00 and USD 17.50.

Largo (LGO.US)

Largo has rebounded in recent weeks. The company disclosed in August 2026 that it finalized a binding term sheet to restructure roughly USD 82.2 million in bank debt, extending the maturity to March 2030. Largo also reported a 68% year-over-year jump in Q2 revenue and began producing copper and platinum group metals as operational byproducts.

Tenax Therapeutics (TENX.US)

Tenax Therapeutics showed volatility following the August 10, 2026 announcement of disappointing topline results from its Phase 3 LEVEL clinical trial, prompting analysts to slash their price targets. Nevertheless, major shareholder ADAR1 Capital Management accumulated approximately USD 1.81 million in common stock throughout late August.

First National Corporation (FNUC.US)

First National Corporation held steady. The firm reported Q2 2026 net income of USD 14.87 million and announced an expansion into family wealth advisory services in mid-August. The bank is currently paying a regular dividend yielding roughly 2.19%.

Orora Limited (ORISF.US)

Orora Limited trended lower after posting its FY2026 results. Total revenue grew 6.5% to USD 2.226 billion, but underlying net profit dropped 5.9% to USD 142.2 million, partly hampered by geopolitical impacts on its Saverglass subsidiary in April. The firm repurchased 175,333 shares on August 24 as part of an ongoing buyback program.

Franco-Nevada (FNV.US)

Franco-Nevada underperformed certain mining peers despite Q2 2026 revenue leaping 57.3% to USD 580.9 million, as both the top line and its USD 1.81 EPS missed Wall Street estimates. The royalty giant continues to diversify its asset base with recent strategic acquisitions.

Silvercorp Metals (SVM.US)

Silvercorp Metals outperformed year-to-date, buoyed by a 135% surge in realized silver prices. For Q1 FY2027 reported in August 2026, revenue jumped 70% to USD 138.7 million, yielding an adjusted net income of USD 53.9 million. In mid-August, the company also reported promising drill results from its Kyzyltash gold project.

This article does not constitute investment advice.